Form 4: DENTSPLY SIRONA SVP Acquires Additional Equity Through RSU Dividends and Phantom Stock
Insider Transaction Report
Andrea L. Frohning, SVP and CHRO of DENTSPLY SIRONA Inc., acquired 304.664 shares of common stock through RSU dividends and 16.7566 phantom stock units from accrued dividends, effective July 11, 2025.
Summary
- Andrea L. Frohning, SVP, CHRO of DENTSPLY SIRONA Inc. (XRAY), acquired additional equity.
- On July 11, 2025, 304.664 shares of common stock were acquired. These represent dividends on restricted stock units (RSUs) and are subject to the same vesting terms as the underlying awards, vesting simultaneously. Each RSU converts to common stock on a 1:1 basis.
- On July 11, 2025, 16.7566 phantom stock units were acquired under the Supplemental Executive Retirement Plan (SERP). These units were comprised of accrued dividends and are the economic equivalent of one share of common stock, payable upon termination of employment.
- Following these transactions, Andrea Frohning beneficially owns 34,040.812 shares of common stock directly and 1,713.6525 phantom stock units directly.
Sentiment
Score: 7
Explanation: The acquisition of additional equity by a senior executive, even if through dividends on existing awards, is generally viewed positively as it increases alignment with shareholder interests. It's a routine compensation event, not a major strategic announcement.
Positives
- Acquisition of additional equity by a senior executive, indicating continued alignment of interests with shareholders.
- The acquisition of common stock through RSU dividends (304.664 shares) and phantom stock through accrued dividends (16.7566 units) increases the executive's beneficial ownership.
Future Outlook
No specific future outlook or guidance is provided, beyond the vesting terms of the RSUs and the payout terms of the phantom stock upon termination of employment.
Industry Context
This Form 4 details an executive's equity compensation, which is a standard practice across industries to align executive incentives with shareholder interests. It does not provide broader industry trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization of Attorney-in-Fact | Andrea Frohning granted a Limited Power of Attorney to Richard Rosenzweig, Jessica Causey, and Lindi Barton-Brobst to execute and file Section 16 reports (Forms 3, 4, and 5) on her behalf. | 2025-05-22 | Streamlines the process for timely and accurate insider transaction reporting for the executive, ensuring compliance with SEC regulations. |
Stakeholder Impact
- Shareholders: Increased alignment of executive's interests with shareholders due to higher equity ownership.
Next Steps
- The acquired restricted stock units (RSUs) will vest according to the terms of the underlying awards.
- The phantom stock units will become payable in common stock upon the reporting person's termination of employment.
Key Dates
| Date | Description |
|---|---|
| 2025-05-22 | Date Andrea Frohning executed the Limited Power of Attorney for Section 16 reporting obligations. |
| 2025-07-11 | Date of transaction for acquisition of common stock and phantom stock units. |
| 2025-07-15 | Date the Form 4 was signed and filed. |
Keywords
DENTSPLY SIRONA, XRAY, SEC Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Phantom Stock, Equity Acquisition, Andrea Frohning, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.